WO2008002676A3 - Biaryl compositions and methods for modulating a kinase cascade - Google Patents
Biaryl compositions and methods for modulating a kinase cascade Download PDFInfo
- Publication number
- WO2008002676A3 WO2008002676A3 PCT/US2007/015273 US2007015273W WO2008002676A3 WO 2008002676 A3 WO2008002676 A3 WO 2008002676A3 US 2007015273 W US2007015273 W US 2007015273W WO 2008002676 A3 WO2008002676 A3 WO 2008002676A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- modulating
- methods
- kinase cascade
- biaryl
- compositions
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/56—Amides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/12—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by halogen atoms or by nitro or nitroso groups
- C07C233/13—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by halogen atoms or by nitro or nitroso groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/16—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
- C07C233/17—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
- C07C233/22—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to an acyclic carbon atom of a carbon skeleton containing six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/44—Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
- C07D213/52—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/89—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Abstract
Priority Applications (10)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SI200731516T SI2041071T1 (en) | 2006-06-29 | 2007-06-29 | Biaryl compositions and methods for modulating a kinase cascade |
EP07810102.9A EP2041071B1 (en) | 2006-06-29 | 2007-06-29 | Biaryl compositions and methods for modulating a kinase cascade |
JP2009518322A JP5564251B2 (en) | 2006-06-29 | 2007-06-29 | Biaryl compositions and methods for modulating kinase cascades |
CN200780031980XA CN101595084B (en) | 2006-06-29 | 2007-06-29 | Biaryl compositions and methods for modulating a kinase cascade |
ES07810102.9T ES2500165T3 (en) | 2006-06-29 | 2007-06-29 | Biaryl compositions and methods to modulate a kinase cascade |
DK07810102.9T DK2041071T3 (en) | 2006-06-29 | 2007-06-29 | BIARLYL COMPOSITIONS AND PROCEDURES FOR MODULATING A CHINA CASE |
AU2007265373A AU2007265373B2 (en) | 2006-06-29 | 2007-06-29 | Biaryl compositions and methods for modulating a kinase cascade |
CA2656564A CA2656564C (en) | 2006-06-29 | 2007-06-29 | Biaryl compositions and methods for modulating a kinase cascade |
IL196168A IL196168A (en) | 2006-06-29 | 2008-12-25 | Use of biaryl compounds for the preparation of medicaments for treating kinase mediated disorders |
IL242374A IL242374A (en) | 2006-06-29 | 2015-10-29 | Biaryl compounds and pharmacetutical compositions containing the same |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11/480,174 US7968574B2 (en) | 2004-12-28 | 2006-06-29 | Biaryl compositions and methods for modulating a kinase cascade |
US11/480,174 | 2006-06-29 | ||
US92349607P | 2007-04-13 | 2007-04-13 | |
US60/923,496 | 2007-04-13 |
Publications (3)
Publication Number | Publication Date |
---|---|
WO2008002676A2 WO2008002676A2 (en) | 2008-01-03 |
WO2008002676A3 true WO2008002676A3 (en) | 2008-05-02 |
WO2008002676A9 WO2008002676A9 (en) | 2008-07-03 |
Family
ID=38821063
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2007/015273 WO2008002676A2 (en) | 2006-06-29 | 2007-06-29 | Biaryl compositions and methods for modulating a kinase cascade |
Country Status (5)
Country | Link |
---|---|
DK (1) | DK2041071T3 (en) |
ES (1) | ES2500165T3 (en) |
IL (1) | IL242374A (en) |
PT (1) | PT2041071E (en) |
WO (1) | WO2008002676A2 (en) |
Families Citing this family (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7968574B2 (en) | 2004-12-28 | 2011-06-28 | Kinex Pharmaceuticals, Llc | Biaryl compositions and methods for modulating a kinase cascade |
US7300931B2 (en) | 2004-12-28 | 2007-11-27 | Kinex Pharmaceuticals, Llc | Compositions for treating cell proliferation disorders |
AU2007265373B2 (en) | 2006-06-29 | 2013-02-21 | Atnx Spv, Llc | Biaryl compositions and methods for modulating a kinase cascade |
US7939529B2 (en) | 2007-05-17 | 2011-05-10 | Kinex Pharmaceuticals, Llc | Process for the preparation of compositions for modulating a kinase cascade and methods of use thereof |
US7935697B2 (en) | 2006-12-28 | 2011-05-03 | Kinex Pharmaceuticals, Llc | Compositions for modulating a kinase cascade and methods of use thereof |
US8124605B2 (en) | 2007-07-06 | 2012-02-28 | Kinex Pharmaceuticals, Llc | Compositions and methods for modulating a kinase cascade |
CN105796568A (en) | 2007-10-20 | 2016-07-27 | 阿西纳斯公司 | Pharmaceutical compositions for modulating a kinase cascade and methods of use thereof |
TWI510241B (en) | 2010-02-18 | 2015-12-01 | Vtv Therapeutice Llc | Phenyl-heteroaryl derivatives and methods of use thereof |
WO2011129936A2 (en) | 2010-04-16 | 2011-10-20 | Kinex Pharmaceuticals, Llc | Compositions and methods for the prevention and treatment of cancer |
EP2590946B1 (en) | 2010-07-05 | 2015-02-18 | Merck Patent GmbH | Bipyridyl derivatives useful for the treatment of kinase-induced diseases |
US9926273B2 (en) * | 2012-08-30 | 2018-03-27 | Athenex, Inc. | Composition and methods for modulating a kinase cascade |
JP6437452B2 (en) | 2013-01-14 | 2018-12-12 | インサイト・ホールディングス・コーポレイションIncyte Holdings Corporation | Bicyclic aromatic carboxamide compounds useful as Pim kinase inhibitors |
ME03780B (en) | 2013-01-15 | 2021-04-20 | Incyte Holdings Corp | Thiazolecarboxamides and pyridinecarboxamide compounds useful as pim kinase inhibitors |
WO2014209034A1 (en) | 2013-06-27 | 2014-12-31 | Lg Life Sciences Ltd. | Biaryl derivatives as gpr120 agonists |
WO2015027124A1 (en) | 2013-08-23 | 2015-02-26 | Incyte Corporation | Furo- and thieno-pyridine carboxamide compounds useful as pim kinase inhibitors |
US9580418B2 (en) | 2014-07-14 | 2017-02-28 | Incyte Corporation | Bicyclic aromatic carboxamide compounds useful as Pim kinase inhibitors |
US9822124B2 (en) | 2014-07-14 | 2017-11-21 | Incyte Corporation | Bicyclic heteroaromatic carboxamide compounds useful as Pim kinase inhibitors |
EP3191449B1 (en) | 2014-09-10 | 2020-07-01 | GlaxoSmithKline Intellectual Property Development Limited | Compounds as rearranged during transfection (ret) inhibitors |
MY181913A (en) | 2014-09-10 | 2021-01-14 | Glaxosmithkline Ip Dev Ltd | Pyridone derivatives as rearranged during transfection (ret) kinase inhibitors |
US9540347B2 (en) | 2015-05-29 | 2017-01-10 | Incyte Corporation | Pyridineamine compounds useful as Pim kinase inhibitors |
AR105967A1 (en) | 2015-09-09 | 2017-11-29 | Incyte Corp | SALTS OF A PIM QUINASA INHIBITOR |
TW201718546A (en) | 2015-10-02 | 2017-06-01 | 英塞特公司 | Heterocyclic compounds useful as PIM kinase inhibitors |
KR20240038149A (en) | 2017-04-26 | 2024-03-22 | 바실리어 파마슈티카 인터내셔널 리미티드 | Processes for the preparation of furazanobenzimidazoles and crystalline forms thereof |
CA3074831A1 (en) | 2017-09-07 | 2019-03-14 | Athenex HK Innovative Limited | Solid forms of 2-(5-(4-(2-morpholinoethoxy)phenyl)pyridin-2-yl)-n-benzylacetamide |
US10596161B2 (en) | 2017-12-08 | 2020-03-24 | Incyte Corporation | Low dose combination therapy for treatment of myeloproliferative neoplasms |
ES2910071T3 (en) | 2018-03-08 | 2022-05-11 | Incyte Corp | Aminopyrazine diol compounds as PI3K-Y inhibitors |
WO2020010003A1 (en) | 2018-07-02 | 2020-01-09 | Incyte Corporation | AMINOPYRAZINE DERIVATIVES AS PI3K-γ INHIBITORS |
CN113461665B (en) * | 2020-03-31 | 2023-05-19 | 成都赜灵生物医药科技有限公司 | Diaryl derivative, preparation method and application thereof |
EP4302831A1 (en) | 2022-07-04 | 2024-01-10 | Trifarma S.p.A. | Process for synthesis of tirbanibulin |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002079197A1 (en) * | 2001-03-29 | 2002-10-10 | Vertex Pharmaceuticals Incorporated | Inhibitors of c-jun n-terminal kinases (jnk) and other protein kinases |
US6538960B1 (en) * | 1999-07-09 | 2003-03-25 | Sony Corporation | Magneto-optical recording medium having a metal heat dispersion layer |
WO2003078404A1 (en) * | 2002-03-15 | 2003-09-25 | Novartis Ag | Pyrimidine derivatives |
WO2004011427A2 (en) * | 2002-07-31 | 2004-02-05 | Smithkline Beecham Corporation | Substituted benzanilides as modulators of the ccr5 receptor |
US20040242572A1 (en) * | 2002-08-24 | 2004-12-02 | Boehringer Ingelheim International Gmbh | New carboxamide compounds having melanin concentrating hormone antagonistic activity, pharmaceutical preparations comprising these compounds and process for their manufacture |
WO2006071960A2 (en) * | 2004-12-28 | 2006-07-06 | Kinex Pharmaceuticals, Llc | Compositions and methods of treating cell proliferation disorders |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4642903A (en) | 1985-03-26 | 1987-02-17 | R. P. Scherer Corporation | Freeze-dried foam dosage form |
US4855326A (en) | 1987-04-20 | 1989-08-08 | Fuisz Pharmaceutical Ltd. | Rapidly dissoluble medicinal dosage unit and method of manufacture |
NZ228645A (en) | 1988-04-11 | 1991-09-25 | Iaf Biochem Int | 1,3-dioxolane derivatives substituted in the 5th position by a purine or pyrimidine radical; treatment of viral infections |
US5578322A (en) | 1990-11-30 | 1996-11-26 | Yamanouchi Pharmaceutical Co., Ltd. | Quick release coated preparation |
US5518730A (en) | 1992-06-03 | 1996-05-21 | Fuisz Technologies Ltd. | Biodegradable controlled release flash flow melt-spun delivery system |
US5380473A (en) | 1992-10-23 | 1995-01-10 | Fuisz Technologies Ltd. | Process for making shearform matrix |
ATE208615T1 (en) | 1993-07-09 | 2001-11-15 | Scherer Corp R P | METHOD FOR PRODUCING FREEZE-DRIED MEDICINAL DOSAGE FORMS |
US5616344A (en) | 1994-06-14 | 1997-04-01 | Fuisz Technologies Ltd. | Apparatus and process for strengthening low density compression dosage units and product therefrom |
US5622719A (en) | 1993-09-10 | 1997-04-22 | Fuisz Technologies Ltd. | Process and apparatus for making rapidly dissolving dosage units and product therefrom |
US5895664A (en) | 1993-09-10 | 1999-04-20 | Fuisz Technologies Ltd. | Process for forming quickly dispersing comestible unit and product therefrom |
US5607697A (en) | 1995-06-07 | 1997-03-04 | Cima Labs, Incorporated | Taste masking microparticles for oral dosage forms |
AU736912B2 (en) | 1997-02-20 | 2001-08-02 | Therics, Inc. | Dosage form exhibiting rapid disperse properties, methods of use and process for the manufacture of same |
US6277406B1 (en) | 1997-10-08 | 2001-08-21 | Fuisz Technologies Ltd. | Easily processed tablet compositions |
US20030130209A1 (en) | 1999-12-22 | 2003-07-10 | Cheresh David A. | Method of treatment of myocardial infarction |
US20040214836A1 (en) | 1998-05-29 | 2004-10-28 | Cheresh David A. | Method of treatment of myocardial infarction |
US7070936B1 (en) | 1999-01-13 | 2006-07-04 | The Research Foundation Of State University Of New York | Method for designing protein kinase inhibitors |
US7005445B2 (en) | 2001-10-22 | 2006-02-28 | The Research Foundation Of State University Of New York | Protein kinase and phosphatase inhibitors and methods for designing them |
AU2002336864B2 (en) | 2001-11-02 | 2006-08-17 | Shire Biochem Inc. | Pharmaceutical compositions for the treatment of leukemia comprising dioxolane nucleosides analogs |
-
2007
- 2007-06-29 DK DK07810102.9T patent/DK2041071T3/en active
- 2007-06-29 PT PT78101029T patent/PT2041071E/en unknown
- 2007-06-29 WO PCT/US2007/015273 patent/WO2008002676A2/en active Application Filing
- 2007-06-29 ES ES07810102.9T patent/ES2500165T3/en active Active
-
2015
- 2015-10-29 IL IL242374A patent/IL242374A/en active IP Right Grant
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6538960B1 (en) * | 1999-07-09 | 2003-03-25 | Sony Corporation | Magneto-optical recording medium having a metal heat dispersion layer |
WO2002079197A1 (en) * | 2001-03-29 | 2002-10-10 | Vertex Pharmaceuticals Incorporated | Inhibitors of c-jun n-terminal kinases (jnk) and other protein kinases |
WO2003078404A1 (en) * | 2002-03-15 | 2003-09-25 | Novartis Ag | Pyrimidine derivatives |
WO2004011427A2 (en) * | 2002-07-31 | 2004-02-05 | Smithkline Beecham Corporation | Substituted benzanilides as modulators of the ccr5 receptor |
US20040242572A1 (en) * | 2002-08-24 | 2004-12-02 | Boehringer Ingelheim International Gmbh | New carboxamide compounds having melanin concentrating hormone antagonistic activity, pharmaceutical preparations comprising these compounds and process for their manufacture |
WO2006071960A2 (en) * | 2004-12-28 | 2006-07-06 | Kinex Pharmaceuticals, Llc | Compositions and methods of treating cell proliferation disorders |
US20060160800A1 (en) * | 2004-12-28 | 2006-07-20 | Hangauer David G Jr | Compositions and methods of treating cell proliferation disorders |
Non-Patent Citations (8)
Title |
---|
BIOORG. MED. CHEM. LETT., vol. 14, no. 4, 2004, pages 983 - 988 * |
DATABASE BEILSTEIN BEILSTEIN INSTITUTE FOR ORGANIC CHEMISTRY, FRANKFURT-MAIN, DE; XP002470813, Database accession no. BRN:7392869 * |
DATABASE BEILSTEIN BEILSTEIN INSTITUTE FOR ORGANIC CHEMISTRY, FRANKFURT-MAIN, DE; XP002470814, Database accession no. BRN:9721347 * |
DATABASE BEILSTEIN BEILSTEIN INSTITUTE FOR ORGANIC CHEMISTRY, FRANKFURT-MAIN, DE; XP002470815, Database accession no. BRN: 9670273 * |
DATABASE BEILSTEIN BEILSTEIN INSTITUTE FOR ORGANIC CHEMISTRY, FRANKFURT-MAIN, DE; XP002470816, Database accession no. BRN: 543268 * |
EUR. J. MED. CHEM. CHIM. THER., vol. 39, no. 1, 2004, pages 11 - 26 * |
J. MED. CHEM, vol. 38, no. 23, 1995, pages 4693 - 4703 * |
J. MED. CHEM., vol. 11, no. 5, 1968, pages 963 * |
Also Published As
Publication number | Publication date |
---|---|
PT2041071E (en) | 2014-09-23 |
DK2041071T3 (en) | 2014-09-01 |
WO2008002676A2 (en) | 2008-01-03 |
ES2500165T3 (en) | 2014-09-30 |
WO2008002676A9 (en) | 2008-07-03 |
IL242374A (en) | 2017-08-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2008002676A3 (en) | Biaryl compositions and methods for modulating a kinase cascade | |
WO2009009041A3 (en) | Compositions and methods for modulating a kinase cascade | |
WO2008002674A3 (en) | Bicyclic compositions and methods for modulating a kinase cascade | |
WO2008014008A3 (en) | Compositions and methods for modulating angiogenesis | |
WO2008112939A3 (en) | Composition and method for making oligo-benzamide compounds | |
WO2011031896A3 (en) | Pi3 kinase inhibitors and uses thereof | |
WO2007093627A3 (en) | Biocidal composition | |
WO2007017423A3 (en) | Pharmaceutical composition comprising a dpp-iv inhibitor | |
WO2007075847A3 (en) | Glucokinase activators | |
IL195341A0 (en) | Methods and materials for making simvastatin and related compounds | |
WO2007130697A3 (en) | Anti-ephb4 antibodies and methods using same | |
WO2008067219A3 (en) | Quinazolinone modulators of tgr5 | |
MX286273B (en) | Compositions and methods for inhibition of the jak pathway. | |
WO2007109254A3 (en) | Stabilized polypeptide compositions | |
WO2008157356A3 (en) | Antibody formulations | |
WO2009077443A3 (en) | Azolylmethyloxiranes, use thereof and agents containing the same | |
WO2007087575A3 (en) | Compositions and methods for treating pulmonary hypertension | |
WO2009077500A3 (en) | Azolylmethyloxiranes, use thereof and agents containing the same | |
WO2006078886A3 (en) | Compounds and compositions as wnt signaling pathway modulators | |
ZA200804026B (en) | Compositions and methods for modulating hemostasis | |
WO2007042288A3 (en) | Kokumi flavour compounds and use | |
IL201064A0 (en) | Janus kinase inhibitor compounds, compositions comprising the same and uses thereof | |
AU2008203254A1 (en) | Compositions of phosphodiesterase type IV inhibitors | |
AU2008266094A8 (en) | Stabilized thrombin compositions | |
WO2008011176A3 (en) | Myosin light chain kinase inhibitor compounds, compositions and related methods of use |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 200780031980.X Country of ref document: CN |
|
DPE1 | Request for preliminary examination filed after expiration of 19th month from priority date (pct application filed from 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2656564 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 196168 Country of ref document: IL |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2009518322 Country of ref document: JP |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2007265373 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2007810102 Country of ref document: EP |
|
NENP | Non-entry into the national phase |
Ref country code: RU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 416/KOLNP/2009 Country of ref document: IN |
|
ENP | Entry into the national phase |
Ref document number: 2007265373 Country of ref document: AU Date of ref document: 20070629 Kind code of ref document: A |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 07810102 Country of ref document: EP Kind code of ref document: A2 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 242374 Country of ref document: IL |